Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b

Cancer Letters

Volumn 261, Issue 2, 2008, Pages 244-252

  Arora, Payal ^a   Kim, Eun Ok ^a   Jung, Jin Kyu ^a   Jang, Kyung Lib ^a  

^a Pusan National University   (South Korea)

Author keywords

Core; DNA methylation; E cadherin; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

CORE PROTEIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; UVOMORULIN;

ARTICLE; CELL AGGREGATION; CELL INTERACTION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; PLASMIDS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 39249084744     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.033     Document Type: Article

References (37)

1. Major M.E., Rehermann B., and Feinstone S.M. Hepatitis C viruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott-Raven Publishers, Philadelphia 1127-1161
2. Kato N., Yoshida H., Kioko Ono-Nita S., Kato J., Goto T., Otsuka M., Lan K., Matsushima K., Shiratori Y., and Omata M. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32 (2000) 405-412
3. Ray R.B., Lagging L.M., Meyer K., and Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryos fibroblasts to tumorigenic phenotype. J. Virol. 70 (1996) 4438-4443
4. Basu A., Meyer K., Lai K.K., Saito K., Di Bisceglie A.M., Grosso L.E., Ray R.B., and Ray R. Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology 349 (2006) 347-358
5. Severi T., Borght S.V., Libbrecht L., Vanaelst L., Nevens F., Roskams T., Cassiman D., Fevery J., Verslype C., and van Pelt J.F. HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. Chem. Biol. Interact. 168 (2007) 128-134
6. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., and Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4 (1998) 1065-1067
7. Hirohashi S., and Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 94 (2003) 575-581
8. Berx G., Cleton-Jansen A.M., Strumane K., de Leeuw W.J., Nollet F., van Roy F., and Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13 (1996) 1919-1925
9. Melki J.R., Vincent P.C., Brown R.D., and Clark S.J. Hypermethylation of E-cadherin in leukemia. Blood 95 (2000) 3208-3213
10. Tamura G., Yin J., Wang S., Fleisher A.S., Zou T., Abraham J.M., Kong D., Smolinski K.N., Wilson K.T., James S.P., Silverberg S.G., Nishizuka S., Terashima M., Motoyama T., and Meltzer S.J. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J. Natl. Cancer. Inst. 92 (2000) 569-573
11. Iwata N., Yamamoto H., Sasaki S., Itoh F., Suzuki H., Kikuchi T., Kaneto H., Iku S., Ozeki I., Karino Y., Satoh T., Toyota J., Satoh M., Endo T., and Imai K. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene 19 (2000) 5298-5302
12. Chang J., Yang S.H., Cho Y.G., Hwang S.B., Hahn Y.S., and Sung Y.C. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J. Virol. 72 (1998) 3060-3065
13. Lee J.O., Kwun H.J., Jung J.K., Choi K.H., Min D.S., and Jang K.L. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24 (2005) 6617-6625
14. Kim M., Shin D., Kim S.I., and Park M. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Virus Res. 122 (2006) 1-10
15. Ting A.H., Jair K.W., Suzuki H., Yen R.W., Baylin S.B., and Schuebel K.E. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Nat. Genet. 36 (2004) 582-584
16. Robert M.F., Morin S., Beaulieu N., Gauthier F., Chute I.C., Barsalou A., and MacLeod A.R. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet. 33 (2003) 61-65
17. Bai S., Ghoshal K., Datta J., Majumder S., Yoon S.O., and Jacob S.T. DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol. Cell. Biol. 25 (2005) 751-766
18. Luo J., Lubaroff D.M., and Hendrix M.J. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res. 59 (1999) 3552-3556
19. Kawanishi J., Kato J., Sasaki K., Fujii S., Watanabe N., and Niitsu Y. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol. Cell. Biol. 15 (1995) 1175-1181
20. Kanai Y., Ushijima S., Hui A.M., Ochiai A., Tsuda H., Sakamoto M., and Hirohashi S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer 71 (1997) 355-359
21. Robertson K.D., Uzvolgyi E., Liang G., Talmadge C., Sumegi J., Gonzales F.A., and Jones P.A. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27 (1999) 2291-2298
22. Robertson K.D. DNA methylation, methyltransferases, and cancer. Oncogene 20 (2001) 3139-3155
23. Saito Y., Kanai Y., Sakamoto M., Saito H., Ishii H., and Hirohashi S. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33 (2001) 561-568
24. Handschuh G., Candidus S., Luber B., Reich U., Schott C., Oswald S., Becke H., Hutzler P., Birchmeier W., Höfler H., and Becker K.F. Tumor-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 29 (1999) 4301-4312
25. Watabe M., Nagafuchi A., Tsukita S., and Takeichi M. Induction, of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell. Biol. 127 (1994) 247-256
26. Tsai C.N., L Tsai C., Tse K.P., Chang H.Y., and Chang Y.S. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl. Acad. Sci. USA 99 (2002) 10084-10089
27. Wu J.C., and Sant D.V. On the mechanism and inhibition of DNA cytosine methyltransferases. Prog. Clin. Biol. Res. 198 (1985) 119-129
28. Rhee I., KE B., BH P., KW J., RW Y., KE S., H C., AP F., Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., Schuebel K.E., Cui H., Feinberg A.P., Lengauer C., Kinzler K.W., Baylin S.B., and Vogelstein B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416 (2002) 552-556
29. Liu K., Wang Y.F., Cantemir C., and Muller M.T. Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo. Mol. Cell. Biol. 23 (2003) 2709-2719
30. Oka M., Rodić N., Graddy J., Chang L.J., and Terada N..J. CpG sites preferentially methylated by Dnmt3a in vivo. Biol. Chem. 281 (2006) 9901-9908
31. Erhardt A., Hassan M., Heintges T., and Haussinger D. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-off cell line. Virology 292 (2002) 272-284
32. Bigey P., Ramchandani S., Theberge J., Araujo F.D., and Szyf M. Transcriptional regulation of the human DNA methyltransferase (dnmt1) gene. Gene 242 (2000) 407-418
33. Tsai C.L., Li H.P., Lu Y.J., Hsueh C., Liang Y., Chen C.L., Tsao S.W., Tse K.P., Yu J.S., and YS C. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH (2)-terminal kinase signaling. Cancer Res. 15 (2006) 11668-11676
34. Hassan M., Ghozlan H., and Abdel-Kader O. Activation of RB/E2F signaling pathway is required for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells. Cell Signal. 16 (2004) 1375-1385
35. INK4a -Cyclin D1-CDK 4/6-pRb-E2F1 Pathway. Cancer Res. 67 (2007) 5771-5778
36. Lara-Pezzi E., Majano P.L., Yáñez-Mó M., Gómez-Gonzalo M., Carretero M., Moreno-Otero R., Sánchez-Madrid F., and López-Cabrera M. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J. Hepatol. 34 (2001) 409-415
37. Nabi I.R. The polarization of the motile cell. J. Cell. Sci. 112 (1999) 1803-1811